多发性骨髓瘤患者影像学应用管理指南
该指南由英国血液学学会制定,基于证据提出多发性骨髓瘤及浆细胞瘤患者诊断与随访中最新影像学技术的使用和技术应用方法。国际骨髓瘤工作组修订的骨髓瘤定义将横断面影像纳入骨病定义及疑似冒烟型骨髓瘤的疾病定义,英国国家卫生与临床优化研究所指南也推荐对疑似骨髓瘤患者行横断面影像。平片曾是初诊检查的标准影像方法,但CT、MRI和18F-FDG PET/CT等横断面影像的证据不断增加,新技术的资金与可及性仍是障碍。
要点
- 国际骨髓瘤工作组修订的骨髓瘤定义将横断面影像纳入骨病定义及疑似冒烟型骨髓瘤的疾病定义。
- 英国国家卫生与临床优化研究所骨髓瘤指南推荐对疑似骨髓瘤患者行横断面影像。
- 国际骨髓瘤工作组近期将影像纳入定义微小残留病阴性的新疗效类别,无论是否有影像学疾病证据。
核心结论
- 作者提出基于证据的方法,用于多发性骨髓瘤和浆细胞瘤患者诊断时及随访中最新影像学模态的使用和技术应用。
研究设计与样本
- 英国血液学学会指南;基于证据的方法,提出多发性骨髓瘤和浆细胞瘤患者诊断时及随访中最新影像学模态的使用和技术应用;原文未报告检索范围、纳入文献、样本量及证据分级方法。
诊断标准与关键数值
- 国际骨髓瘤工作组修订的骨髓瘤定义将横断面影像作为定义骨病的方法,并纳入疑似冒烟型骨髓瘤患者的疾病定义。
- 英国国家卫生与临床优化研究所骨髓瘤指南推荐对疑似骨髓瘤患者行横断面影像。
- 国际骨髓瘤工作组近期将影像纳入定义微小残留病阴性的新疗效类别,无论是否有影像学疾病证据。
临床应用与阅片要点
- 平片既往是初诊骨髓瘤检查中纳入的标准影像模态,但CT、MRI和18F-FDG PET/CT等横断面模态的证据不断增加。
- 新影像技术的资金与可及性仍是障碍。
- 原文未据此给出具体推荐条款及推荐等级。
局限性
- 新影像技术的资金与可及性仍是障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The role of imaging in myeloma has gained increasing importance over the past few years. The recently revised definition of myeloma from the International Myeloma Working Group (IMWG) includes cross sectional imaging as a method to define bone disease and also incorporates its use in the disease definition for patients with suspected smouldering myeloma. The National Institute for Health and Care Excellence myeloma guidelines also recommend cross sectional imaging for patients with suspected myeloma. There is also increasing use of imaging in disease assessments and the International Myeloma Working Group has recently incorporated imaging in defining new response categories of minimal residual disease negativity, with or without imaging-based evidence of disease. Plain X-rays have previously been the standard imaging modality included in a myeloma work up at presentation but evidence is mounting for use of cross-sectional modalities such as computed tomography (CT), magnetic resonance imaging (MRI) and 18 fluoro-deoxyglucose (18 F-FDG) positron emission tomography (PET)/CT. Funding and therefore availability of newer imaging techniques remains a barrier. Here, we propose an evidence-based approach to the use and technical application of the latest imaging modalities at diagnosis and in the follow-up of patients with myeloma and plasmacytoma.
引用
- Chantry A, Kazmi M, Barrington S, et al. Guidelines for the use of imaging in the management of patients with myeloma. Br J Haematol. 2017. PMID: 28677897. doi:10.1111/bjh.14827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。